{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:29:10Z","timestamp":1792794550694,"version":"4.5.0"},"reference-count":24,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi260075-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>\n                      Current data on\n                      <jats:italic toggle=\"yes\">Candida<\/jats:italic>\n                      bloodstream infection (candidemia) in solid organ transplant recipients (SOTRs) are constrained by small sample sizes. Further research may inform targeted prevention strategies for early intervention.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260075-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine the incidence and outcomes of candidemia in SOTRs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260075-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>A population-based cohort study using a provincewide mycology laboratory dataset of patients aged 18 or more years from Ontario, Canada, who received an organ allograft between January 1, 2011, and September 30, 2022, with follow-up through December 31, 2023, and linked to administrative health care data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260075-7\">\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>Organ transplant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260075-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcome was candidemia incidence, estimated using the Kaplan-Meier method, with differences across SOTRs evaluated via the log-rank test. The secondary outcome was all-cause mortality, evaluated using a Cox proportional hazards regression model with candidemia as a time-dependent variable. Analyses were adjusted for relevant covariates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260075-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      This study included 10\u202f249 SOTRs (median age, 57 [IQR, 46-64] years; 63.9% male), with kidney transplants representing the majority (59.8%). Candidemia occurred in 135 patients, with\n                      <jats:italic toggle=\"yes\">Candida albicans<\/jats:italic>\n                      as the most frequent species (41.5%), followed by\n                      <jats:italic toggle=\"yes\">Nakaseomyces<\/jats:italic>\n                      (\n                      <jats:italic toggle=\"yes\">Candida<\/jats:italic>\n                      )\n                      <jats:italic toggle=\"yes\">glabrata<\/jats:italic>\n                      (28.1%) and\n                      <jats:italic toggle=\"yes\">C parapsilosis<\/jats:italic>\n                      (11.9%). The cumulative probability of candidemia was 0.87% (95% CI, 0.69%-1.05%) at 1 year, 1.33% (95% CI, 1.09%-1.57%) at 5 years, and 1.67% (95% CI, 1.34%-2.00%) at 10 years. Lung transplant recipients had the highest 10-year cumulative probability at 4.17% (95% CI, 2.96%-5.39%; log-rank\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001). Median time to candidemia was 34 (IQR, 18.5-354) days in recipients of thoracic allografts and 174 (IQR, 20-836) days in recipients of abdominal allografts. Thirty-day mortality was 39.3% (53 of 135) and 90-day mortality was 47.4% (64 of 135) in patients with candidemia. Candidemia was associated with an increase in mortality (adjusted hazard ratio [AHR], 6.85; 95% CI, 5.59-8.39;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001). Fluconazole-susceptible isolates were associated with an increase in mortality (AHR, 8.45; 95% CI, 6.42-11.14;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001) as were fluconazole-resistant\n                      <jats:italic toggle=\"yes\">Candida<\/jats:italic>\n                      isolates (AHR, 11.86; 95% CI, 6.13-22.93;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260075-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this cohort study of SOTRs, candidemia was an uncommon complication after organ transplant, with lung transplant recipients at the highest risk. Candidemia was associated with increased mortality. Further research is needed to better identify vulnerable subpopulations and to develop targeted strategies for early intervention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.1467","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T15:00:41Z","timestamp":1773759641000},"page":"e261467","source":"Crossref","is-referenced-by-count":2,"title":["Incidence and Outcomes of\n                    <i>Candida<\/i>\n                    Bloodstream Infection in Solid Organ Transplant Recipients"],"prefix":"10.1001","volume":"9","author":[{"given":"Roni","family":"Bitterman","sequence":"first","affiliation":[{"name":"Transplant Infectious Diseases, Ajmera Transplant Centre, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julianne V.","family":"Kus","sequence":"additional","affiliation":[{"name":"Public Health Ontario, Toronto, Ontario, Canada"},{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geena","family":"Verma","sequence":"additional","affiliation":[{"name":"ICES, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kopp","sequence":"additional","affiliation":[{"name":"ICES, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahid","family":"Husain","sequence":"additional","affiliation":[{"name":"Transplant Infectious Diseases, Ajmera Transplant Centre, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey C.","family":"Kwong","sequence":"additional","affiliation":[{"name":"Public Health Ontario, Toronto, Ontario, Canada"},{"name":"ICES, Ontario, Canada"},{"name":"Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed M.","family":"Hosseini-Moghaddam","sequence":"additional","affiliation":[{"name":"Transplant Infectious Diseases, Ajmera Transplant Centre, University Health Network, Toronto, Ontario, Canada"},{"name":"ICES, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"issue":"8","key":"zoi260075r1","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"2","key":"zoi260075r2","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13250","article-title":"Incidence and outcomes of invasive fungal infection among solid organ transplant recipients: a population-based cohort study.","volume":"22","author":"Hosseini-Moghaddam","year":"2020","journal-title":"Transpl Infect Dis"},{"issue":"3","key":"zoi260075r3","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1399-3062.2010.00492.x","article-title":"Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients.","volume":"12","author":"Neofytos","year":"2010","journal-title":"Transpl Infect Dis"},{"issue":"7","key":"zoi260075r4","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.1093\/cid\/ciz1113","article-title":"Burden and timeline of infectious diseases in the first year after solid organ transplantation in the Swiss Transplant Cohort Study.","volume":"71","author":"van Delden","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"6","key":"zoi260075r5","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/tid.12613","article-title":"The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).","volume":"18","author":"Andes","year":"2016","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"zoi260075r6","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/j.1399-3062.2009.00371.x","article-title":"Candidemia following solid organ transplantation in the era of antifungal prophylaxis: the Australian experience.","volume":"11","author":"van Hal","year":"2009","journal-title":"Transpl Infect Dis"},{"issue":"9","key":"zoi260075r7","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13623","article-title":"Candida infections in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.","volume":"33","author":"Aslam","year":"2019","journal-title":"Clin Transplant"},{"issue":"4","key":"zoi260075r8","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.diagmicrobio.2012.10.003","article-title":"Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance\u00ae) registry, 2004-2008.","volume":"74","author":"Pfaller","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"10","key":"zoi260075r9","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.cmi.2019.04.024","article-title":"Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis.","volume":"25","author":"Koehler","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"zoi260075r10","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1093\/jac\/dkad139","article-title":"Invasive candidiasis: current clinical challenges and unmet needs in adult populations.","volume":"78","author":"Soriano","year":"2023","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"zoi260075r11","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13195","article-title":"Candidemia in solid organ transplant recipients in Spain: epidemiological trends and determinants of outcome.","volume":"21","author":"Fern\u00e1ndez-Ruiz","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"zoi260075r12","doi-asserted-by":"publisher","first-page":"160","DOI":"10.6002\/ect","article-title":"Evaluation of candidemia in solid-organ transplant recipients.","volume":"22","author":"Sari","year":"2024","journal-title":"Exp Clin Transplant"},{"issue":"9","key":"zoi260075r13","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.15038","article-title":"Candidemia in thoracic solid organ transplant recipients: characteristics and outcomes relative to matched uninfected and bacteremic thoracic organ transplant recipients.","volume":"37","author":"Eichenberger","year":"2023","journal-title":"Clin Transplant"},{"issue":"5","key":"zoi260075r16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"2","key":"zoi260075r17","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.chest.2021.08.081","article-title":"Risk factors for invasive Candida infection in critically ill patients: a systematic review and meta-analysis.","volume":"161","author":"Thomas-R\u00fcddel","year":"2022","journal-title":"Chest"},{"issue":"1","key":"zoi260075r18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13054-020-2766-1","article-title":"Risk factors for candidemia: a prospective matched case-control study.","volume":"24","author":"Poissy","year":"2020","journal-title":"Crit Care"},{"issue":"1","key":"zoi260075r19","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s13054-019-2497-3","article-title":"Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project.","volume":"23","author":"Bassetti","year":"2019","journal-title":"Crit Care"},{"issue":"3","key":"zoi260075r20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106229","article-title":"Attributable mortality of candidemia\u2014results from the ECMM Candida III multinational European Observational Cohort Study.","volume":"89","author":"Salmanton-Garc\u00eda","year":"2024","journal-title":"J Infect"},{"issue":"9","key":"zoi260075r21","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1007\/s10096-019-03611-1","article-title":"The association between fluconazole dose and MIC with mortality and persistence in candidemia.","volume":"38","author":"Ghanem-Zoubi","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"zoi260075r22","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3201\/eid2703.203482","article-title":"Fluconazole-resistant Candida glabrata bloodstream isolates, South Korea, 2008-2018.","volume":"27","author":"Won","year":"2021","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"zoi260075r23","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/cid\/ciae603","article-title":"Impact of fluconazole resistance on the outcomes of patients with Candida parapsilosis bloodstream infections: a retrospective multicenter study.","volume":"80","author":"Vena","year":"2025","journal-title":"Clin Infect Dis"},{"issue":"1","key":"zoi260075r24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40697-015-0054-9","article-title":"Validation of kidney transplantation using administrative data.","volume":"2","author":"Lam","year":"2015","journal-title":"Can J Kidney Health Dis"},{"key":"zoi260075r15","volume-title":"Performance Standards for Antifungal Susceptibility Testing of Yeasts","author":"Clinical and Laboratory Standards Institute","year":"2022","edition":"3rd ed"},{"key":"zoi260075r14","unstructured":"Canadian Institute of Health Information (CIHI). Summary statistics on organ transplants. 2024. Accessed January 23, 2025. https:\/\/www.cihi.ca\/en\/summary-statistics-on-organ-transplants-wait-lists-and-donors"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2846560\/bitterman_2026_oi_260075_1773168015.24055.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T15:00:43Z","timestamp":1773759643000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2846560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.1467","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]}}}